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Commentary: Lung cancer
resections during the pandemic
THOR

Rohit Shenoy, MD, and Ikenna Okereke, MD
The COVID-19 pandemic had a significant effect on health
care delivery systems across the country. Because of the
need to allocate resources adequately, only selected elective
surgeries were performed during parts of the pandemic. The
time-sensitive nature of pulmonary resections for lung cancer meant that many of these cases were given priority. This
study by Villena-Vargas and colleagues1 aims to highlight
the safety of lung cancer surgery at a New York hospital
during the worst period of the pandemic. The location of
this study is important because New York was one of the
earliest and most affected regions of the country during
this pandemic.2
The authors compared 2 groups—the first group representing patients in the 3 months immediately preceding
the pandemic and the second group representing patients
receiving operations between March 2020 and June 2020.
Most of the patients in both groups underwent minimally
invasive surgery with comparable oncologic parameters
on final pathologic review. There was a relatively low rate
of 90-day COVID-19 infection, with only 3 of 41 patients
who received their operation during the pandemic period
developing disease. Two of these 3 patients ultimately
died of COVID-19.
This study highlights the fact that surgery can be performed safely during a pandemic, but there are many additional factors that need to be known. First, this study was
very small. Second, the rate at which operations were
done was much lower than in the prepandemic period.
Although it seems that surgery can be performed safely,
there are still questions about which patients should be deferred. Third, since this study was performed the vaccine
was developed and distributed. Decision-making about
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Patients who underwent resection for lung cancer were not at
increased risk for contracting
COVID-19 during the pandemic.
Postoperative COVID infection
has a 40% mortality warranting
close follow-up.
eligibility for surgery has changed dramatically since
2020 with the availability of the vaccine.
The decision to delay an operation is not trivial. Some
high-risk patients requiring surgery for lung cancer might
occasionally require intensive care unit admission and
need for mechanical ventilation.3 In the setting of an
ongoing pandemic, prolonged ventilation is not ideal
for multiple reasons. However, delays in operation for
lung cancer might be associated with upstaging of disease
and decreased median survival.4 Going forward, our specialty will need to determine which patients can receive
operations safely during a major public health crisis.
We have learned some lessons from the past 20 months,
but ongoing studies are needed for more detailed
recommendations.
I applaud the authors for continuing the essential service
of cancer surgery during the worst pandemic of our lifetimes.so far. As climate change continues to occur, we
should expect that we will face future infectious disease catastrophes.5 The authors do acknowledge that their study
was limited by a small sample size. In addition, this study
was performed before development of the vaccine. Nevertheless, we can learn some lessons from their article. It
does appear that with appropriate patient selection, cancer
surgery can be performed during a pandemic with a low
transmission rate.
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Commentary: Coronavirus disease
2019 (COVID-19): Adaptive
realignment makes me want to
work eight days a week
Richard Lazzaro, MD, FACS,a,b and
Matthew Inra, MDa,b
In this month’s issue of the Journal, Villena-Vargas and colleagues1 report on the “safety of lung cancer surgery during
COVID-19 in a pandemic epicenter.” The authors retrospectively reviewed a prospective database and identified
57 patients who underwent lung cancer resection before
the pandemic (January 1, 2020, to March 10, 2020), and
41 patients during the initial phase of the pandemic (March
11, 2020, to June 10, 2020) who underwent lung cancer
resection, with a primary end point of acquisition of severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection during the first 90 days after surgery. Both 90day perioperative morbidity and mortality were recorded
as secondary end points. Acquisition of SARS-CoV-2 infection during the first 90 days after surgery was not significantly different between the 2 groups but tended to be
more frequently acquired during the pandemic; 3.5% (2/
57) of patients operated on before the pandemic and
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Adaptive realignment allows
hospitals and health systems to
adapt to the system strains
encountered by future pandemics and maintain surgical
volume for better patient care
and hospital ﬁscal health.

7.3% (3/41) of patients during the initial phase of the
pandemic acquired SARS-CoV-2 infection. Consistent
with previous reports, acquisition of SARS-CoV-2 infection
is associated with high mortality.1
The pandemic has affected all of us. A surgeon often reflects about quality, volume, academics, and mentoring.
Experience leads to good judgment. We had no experience
with SARS-CoV-2 before the pandemic and witnessed health
systems and hospitals adapt immediately to an unknown foe.
Intensive care units filled quickly to capacity, personal protective equipment was scarce, and resources to deliver patient care required limitations to elective surgery. “Shortage
of ICU beds during the peaks / cancelling scheduled surgeries due to the lack of beds / hospital financial losses
/ staff furloughs / exacerbated shortage of staffed hospital beds coupled with ED overcrowding / delays in
resuming elective surgeries and intensified financial strain.”2
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